Korean J Med.
2009 Aug;77(Suppl 1):S31-S35.
A case of fulminant hepatic failure due to cyproterone acetate in a patient with cryptogenic liver cirrhosis
- Affiliations
-
- 1Department of Internal Medicine, College of Medicine, Hallym University, Chuncheon, Korea. djkim@hallym.ac.kr
- 2Department of Pathology, College of Medicine, Hallym University, Chuncheon, Korea.
Abstract
- Cyproterone acetate is an antiandrogenic drug that has been used in prostatic cancer. The drug is thought to be well-tolerated but has hepatotoxic effects. An 89 year-old man treated with cyproterone acetate 300 mg/d for prostatic cancer presented with a hepatotoxic reaction. Toxic hepatitis was diagnosed and cyproterone acetate was stopped immediately. The patient was treated with supportive management and a corticosteroid, but he died 28 days after administration due to liver failure. A liver biopsy performed after his death revealed the presence of acute hepatitis with cirrhosis. Underlying cirrhosis was not suspected before his death. Ultimately, the case was diagnosed as fulminant hepatic failure due to cyproterone acetate with underlying cryptogenic liver cirrhosis. This case and current literature highlight the hepatotoxic potential of cyproterone acetate and illustrate the importance of clinical surveillance, especially in patients with unrecognized liver disease.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Three Cases of Fulminant Hepatic Failure due to Congestive Heart Failure
- Acute Hepatic Failure after Spinal Surgery in Patient with Liver Cirrhosis: A case report
- A case of fulminant hepatic failure complicating hepatitis A virus superinfection in a hepatitis B virus carrier
- Intermittent Androgen Deprivation(IAD) with Cyproterone Acetate Monotherapy for Prostate Cancer: A preliminary report
- A Case of Fulminant Hepatic Failure Secondary to Hepatic Metastasis of Small Cell Lung Carcinoma
